Stamp Out Lyme Disease Act

HR 4413, the Stamp Out Lyme Disease Act, authorizes the U.S. Postal Service to sell a special semipostal stamp (where the price exceeds regular postage) to fund Lyme disease research. The extra revenue from stamp sales will be sent directly to the National Institute of Allergy and Infectious Diseases (NIAID) for tick-borne illness research, with funds specifically protected from being used to offset NIAID's regular budget. The stamp would be available for at least six years, beginning one year after the bill becomes law, and the proceeds cannot reduce other federal funding for NIAID. This bill creates a new public funding mechanism for research, directly affecting those who purchase the stamp and the NIAID research programs.